(rw) de-identified clinicogenomic database. Patients who initiated therapy forEGFR-mutated aNSCLC between January 2014 and December 2020 were identified. Clinical outcomes were evaluated byTP53-mutational status. In 356 eligibleEGFR-mutated aNSCLC patients (median age 68 years), 210 (59.0%) had...